{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:25:58Z","timestamp":1787840758874,"version":"build-2784847793"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>\n                    Brucellosis is a common zoonotic infection caused by bacterial genus\n                    <jats:italic toggle=\"yes\">Brucella<\/jats:italic>\n                    , a Gram-negative bacterium, and continued to be a health problem in endemic areas. Anti-\n                    <jats:italic toggle=\"yes\">N<\/jats:italic>\n                    -methyl-d-aspartate receptor (NMDAR) encephalitis is an autoimmune disease which can lead to status epilepticus. A 19-year-old male patient was referred to our hospital with status epilepticus. The diagnosis of brucellosis was confirmed about 2 weeks before. The brain magnetic resonance imaging was normal. Lumbar puncture was performed, and cerebral spinal fluid (CSF) was in normal limits. The patient was treated with antiepileptic, anti-brucellosis agents. Two weeks after discharge, the patient readmitted to hospital with status epilepticus again. Extensive workup was negative except that NMDAR antibodies were detected in serum and CSF. The diagnosis of anti-NMDAR encephalitis was established. Brucellosis as a triggering factor for NMDAR encephalitis should be considered.\n                  <\/jats:p>","DOI":"10.4103\/ijpvm.ijpvm_417_18","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T05:46:45Z","timestamp":1578548805000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Anti-NMDA Receptor Encephalitis Presenting with Status Epilepticus: Brucellosis as a Possible Triggering Factor: A Case Report"],"prefix":"10.4103","volume":"10","author":[{"given":"Atousa","family":"Hakamifard","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Navid","family":"Naghibi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kashani Hospital Epilepsy Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Sohrab","family":"Hashemi Fesharaki","sequence":"additional","affiliation":[{"name":"Pars Advanced Medical Research Center, Pars Hospital, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"R1-20250812","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0255-0857(21)02105-8","article-title":"Review of clinical and laboratory features of human brucellosis","volume":"25","author":"Mantur","year":"2007","journal-title":"Indian J Med Microbiol"},{"key":"R2-20250812","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1179\/joc.2007.19.3.243","article-title":"Brucellosis in Middle East: A persistent medical, socioeconomic and political issue","volume":"19","author":"Pappas","year":"2007","journal-title":"J Chemother"},{"key":"R3-20250812","first-page":"358","article-title":"The effect of lifestyle on brucellosis among nomads in Iran, Ahvaz","volume":"23","author":"Alavi","year":"2007","journal-title":"Pak J Med Sci"},{"key":"R4-20250812","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(07)70286-4","article-title":"Human brucellosis","volume":"7","author":"Franco","year":"2007","journal-title":"The Lancet Infectious Dis"},{"key":"R5-20250812","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMra050570","article-title":"Medical progress: Brucellosis","volume":"352","author":"Pappas","year":"2005","journal-title":"N E J Med"},{"key":"R6-20250812","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.yebeh.2015.04.032","article-title":"EEG extreme delta brush: An ictal pattern in patients with anti-NMDA receptor encephalitis","volume":"49","author":"Veciana","year":"2015","journal-title":"Epilepsy Behav"},{"key":"R7-20250812","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2012.03.001","article-title":"Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology","volume":"11","author":"Peery","year":"2012","journal-title":"Autoimmun Rev"},{"key":"R8-20250812","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12028-012-9788-8","article-title":"Anti-Nmethyl-D-aspartate receptor encephalitis with favorable outcome despite prolonged status epilepticus","volume":"18","author":"Finn\u00e9 Lenoir","year":"2013","journal-title":"Neurocrit Care"},{"key":"R9-20250812","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1528-1167.2008.01993.x","article-title":"Duration of refractory status epilepticus and outcome: Loss of prognostic utility after several hours","volume":"50","author":"Drislane","year":"2009","journal-title":"Epilepsia"},{"key":"R10-20250812","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"R11-20250812","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-Daspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"key":"R12-20250812","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"T\u00fcz\u00fcn","year":"2009","journal-title":"Acta Neuropathol"},{"key":"R13-20250812","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1460-9568.2010.07349.x","article-title":"Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: Insights from molecular, cellular and synaptic studies","volume":"32","author":"Moscato","year":"2010","journal-title":"Eur J Neurosci"},{"key":"R14-20250812","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: Case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"}],"container-title":["International Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01439446-201910000-00117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:28:25Z","timestamp":1787837305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01439446-201910000-00117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpvm.ijpvm_417_18","relation":{},"ISSN":["2008-7802","2008-8213"],"issn-type":[{"value":"2008-7802","type":"print"},{"value":"2008-8213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"2018-09-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}